Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines

İDİLMAN R.

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.28, sa.6, ss.518-521, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5152/tjg.2017.171017
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.518-521
  • Anahtar Kelimeler: Hepatitis B virus, special patient group, pregnancy, dialysis patients, TRANSPLANTATION, TRANSMISSION, REACTIVATION, PROPHYLAXIS, PREVENTION, TENOFOVIR
  • Ankara Üniversitesi Adresli: Evet

Özet

The morbidity and mortality of hepatitis B virus-related liver disease are linked to the persistence of the hepatitis B virus replication. Viral suppression with antiviral therapy has been shown to provide clinical benefits. Several special groups of patients with hepatitis B virus infection require special attention. In this brief report, based on European Association for the Study of the Liver 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, the current optimal management of special patient groups with hepatitis B virus infection is summarized.